BCRX
BioCryst Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $1.52B | Price | $7.32 |
| Volume | 5.73M | Change | +0.97% |
| P/E Ratio | -17.1 | Open | $7.28 |
| Revenue | $450.7M | Prev Close | $7.25 |
| Net Income | $-88.9M | 52W Range | $6.00 - $11.31 |
| Div Yield | N/A | Target | $20.27 |
| Overall | 48 | Value | 30 |
| Quality | 60 | Technical | 54 |
No chart data available
Stock Overview
Updated DailyBioCryst Pharmaceuticals Inc. (BCRX) is a leading Healthcare company in the Biotechnology industry, currently trading at $7.32 with a market capitalization of $1.52 billion. The stock is in the lower portion of its trading range, demonstrating solid quality metrics with a MarketXLS quality score of 60.
Today's trading session shows BCRX with a volume of 5.73 million shares. The stock opened up 0.41% from yesterday's close of $7.25. Current analyst estimates project earnings of $0.17 per share for this year, with next year targeting $0.39.
BCRX demonstrates neutral technical outlook based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including RGEN, SRPT, NNVC, NVAX, GILD.
Key investment considerations for BCRX include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 176.9%. The stock shows expensive valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 10:27 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCRX | $7.32 | +1.0% | 5.73M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get BioCryst Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW